Progressive Multifocal Leukoencephalopathy after Administration of Front-Line Obinutuzumab and Venetoclax in a Patient with Chronic Lymphocytic Leukemia: Case Report
PML is a rare complication of anti-CD 20 monoclonal antibodies, including obinutuzumab. Early recognition of PML is essential to discontinue an affecting drug and initiate therapy.
Authors
- Andrew R. Maher (ORCID: https://orcid.org/0000-0003-1079-3684)
- Rouslan Kotchetkov (ORCID: https://orcid.org/0000-0002-9851-0089)
Institutions
- Queen's University (CA)
- Royal Victoria Regional Health Centre (CA)
Publication Details
- Journal
- Case Reports in Oncology
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1159/000549388
- Citations
- 1
- Primary Topic
- Polyomavirus and related diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.05